Schwannoma epidemiology and demographics

Jump to navigation Jump to search

Schwannoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Schwannoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Schwannoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Schwannoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Schwannoma epidemiology and demographics

CDC on Schwannoma epidemiology and demographics

Schwannoma epidemiology and demographics in the news

Blogs on Schwannoma epidemiology and demographics

Directions to Hospitals Treating Schwannoma

Risk calculators and risk factors for Schwannoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]

Overview

The incidence vestibular schwannoma is approximately 1 per 100,000 individuals. Patients of all age groups may develop vestibular schwannoma. The incidence is more common between the 3rd and 5th decades of life. The median age at diagnosis is 5th decade. The incidence seems to be higher in Asian population and lower in Hispanics and African-Americans. Vestibular schwannoma affects men and women equally with a slight predilection towards female population.

Epidemiology and demographics

Incidence

  • The incidence vestibular schwannoma is approximately 1 per 100,000 individuals.

Age

  • Patients of all age groups may develop vestibular schwannoma.
  • The incidence is more common between the 3rd and 5th decades of life.
  • The median age at diagnosis is 5th decade.[1]

Race

  • The incidence seems to be higher in Asian population and lower in Hispanics and African-Americans.[2]

Gender

  • Vestibular schwannoma affects men and women equally with a slight predilection towards female population. [3]


References

  1. Propp JM, McCarthy BJ, Davis FG, Preston-Martin S (January 2006). "Descriptive epidemiology of vestibular schwannomas". Neuro-oncology. 8 (1): 1–11. doi:10.1215/S1522851704001097. PMC 1871924. PMID 16443943.
  2. Koo M, Lai JT, Yang EY, Liu TC, Hwang JH (October 2018). "Incidence of Vestibular Schwannoma in Taiwan from 2001 to 2012: A Population-Based National Health Insurance Study". Ann. Otol. Rhinol. Laryngol. 127 (10): 694–697. doi:10.1177/0003489418788385. PMID 30032646.
  3. Brown CM, Ahmad ZK, Ryan AF, Doherty JK (January 2011). "Estrogen receptor expression in sporadic vestibular schwannomas". Otol. Neurotol. 32 (1): 158–62. doi:10.1097/MAO.0b013e3181feb92a. PMC 3073320. PMID 21099731.



Template:WikiDoc Sources